News

Immunotherapy Breaks Tumor Defenses and Clears Metastatic Cancer

Immunotherapy /

Scientists have created a new type of immunotherapy that fights metastatic cancer by attacking the tumor’s protective cells instead of the cancer cells themselves. This approach is designed to overcome the resistance seen in many solid tumors such as lung and ovarian cancer. Solid tumors often surround themselves with tumor-associated macrophages—immune cells that are reprogrammed […]

Immunotherapy Breaks Tumor Defenses and Clears Metastatic Cancer Read More »

Study Reveals How Pancreatic Cancer Reprograms Tissue to Spread Early Through Nerves

Research Advances /

A new study explains how pancreatic cancer becomes aggressive and spreads very early. Researchers found that the tumor can “reprogram” its surrounding environment, allowing cancer cells to invade nearby nerves and use them as pathways to spread through the body, a process known as perineural invasion. The study shows that pancreatic tumors depend on support

Study Reveals How Pancreatic Cancer Reprograms Tissue to Spread Early Through Nerves Read More »

Immune “Memory” Marker Explains 20-Year Survival After Breast Cancer Vaccine

Research Advances /

A new study explains why a small group of women with advanced breast cancer lived more than 20 years after receiving an experimental cancer vaccine. Researchers discovered that these long-term survivors shared a special immune “memory” marker called CD27, which helps the immune system remember and fight cancer for decades. This finding is unusual because

Immune “Memory” Marker Explains 20-Year Survival After Breast Cancer Vaccine Read More »

New Drug Combination Targets Genetic Weakness in Pancreatic Cancer

Precision Medicine /

Researches have presented a new treatment strategy for pancreatic ductal adenocarcinoma (PDAC), a highly aggressive cancer with a survival rate of about 13%. While most PDAC cases have KRAS mutations, around 22% also lose the MTAP gene. This MTAP deletion causes a buildup of a molecule called MTA, creating a unique weakness in cancer cells. Researchers developed a

New Drug Combination Targets Genetic Weakness in Pancreatic Cancer Read More »

New Antibody Ginisortamab Shows Promise Against Advanced Gastrointestinal Cancers

Treatment /

Ginisortamab (UCB6114) is a new monoclonal antibody being developed to treat advanced solid tumors, especially gastrointestinal cancers. Instead of attacking cancer cells directly, it targets the tumor’s surrounding support cells to weaken the tumor’s defenses. The therapy focuses on a protein called gremlin-1, produced by cancer-associated fibroblasts around the tumor. Gremlin-1 blocks natural tumor-suppressing proteins

New Antibody Ginisortamab Shows Promise Against Advanced Gastrointestinal Cancers Read More »

New LED and Tin Nanoflake Therapy Offers Safe, Low-Cost Cancer Treatment

Technology Innovation /

Researchers have developed a low-cost, non-invasive cancer treatment that uses LED light and tin-based nanoflakes to destroy tumors without the harsh side effects of chemotherapy. The treatment works by giving patients ultra-thin tin oxide (SnOx) nanoflakes that target cancer cells. When exposed to simple LED light, the nanoflakes heat up and kill the cancer cells

New LED and Tin Nanoflake Therapy Offers Safe, Low-Cost Cancer Treatment Read More »

Scientists Grow Helper T Cells from Stem Cells, Paving the Way for Faster, Cheaper Cancer Therapies

Research Advances /

Researchers have found a way to consistently grow Helper T cells from stem cells in the lab, a breakthrough that could make advanced cancer therapies faster, cheaper, and more accessible. Helper T cells are important because they coordinate and strengthen the immune response, but until now they were very difficult to produce reliably. The team

Scientists Grow Helper T Cells from Stem Cells, Paving the Way for Faster, Cheaper Cancer Therapies Read More »

New Antibody Shows Promise Against Aggressive Triple-Negative Breast Cancer

Treatment /

Researchers have developed an experimental antibody that targets triple-negative breast cancer, one of the most aggressive and treatment-resistant forms of the disease. The antibody focuses on a protein called SFRP2, which helps tumors grow, survive chemotherapy, and evade the immune system. The treatment works by blocking SFRP2, which flips tumor-supporting immune cells called macrophages back into

New Antibody Shows Promise Against Aggressive Triple-Negative Breast Cancer Read More »

Scientists Uncover How Pancreatic Cancer Hides From the Immune System—and How to Expose It

Research Advances /

Research have discovered how pancreatic cancer hides from the immune system. The researchers found that this “invisibility cloak” can be disabled, causing aggressive tumors in animal studies to shrink by as much as 94%. The study focused on MYC, a protein known to drive rapid cancer growth. While MYC’s role in making tumors grow was already

Scientists Uncover How Pancreatic Cancer Hides From the Immune System—and How to Expose It Read More »

New Tool Predicts How Cancer Evolves by Tracking Chromosome Changes

Technology Innovation /

Researchers have created ALFA-K, a computer-based tool that predicts how cancer changes over time by tracking whole chromosomes. Instead of just observing tumors at one moment, this approach helps forecast how they will evolve. Cancer cells often gain or lose entire chromosomes, which can change thousands of genes at once. Until now, it was difficult

New Tool Predicts How Cancer Evolves by Tracking Chromosome Changes Read More »